Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Common Equity (2020 - 2025)

NeuroPace (NPCE) has 6 years of Common Equity data on record, last reported at $19.0 million in Q4 2025.

  • For Q4 2025, Common Equity rose 137.5% year-over-year to $19.0 million; the TTM value through Dec 2025 reached $19.0 million, up 137.5%, while the annual FY2025 figure was $19.0 million, 137.5% up from the prior year.
  • Common Equity reached $19.0 million in Q4 2025 per NPCE's latest filing, up from $18.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $88.7 million in Q2 2021 and bottomed at -$156.4 million in Q1 2021.
  • Average Common Equity over 5 years is $24.5 million, with a median of $20.9 million recorded in 2023.
  • Peak YoY movement for Common Equity: soared 161.45% in 2021, then crashed 62.31% in 2023.
  • A 5-year view of Common Equity shows it stood at $73.5 million in 2021, then tumbled by 52.69% to $34.8 million in 2022, then crashed by 40.61% to $20.7 million in 2023, then crashed by 61.2% to $8.0 million in 2024, then soared by 137.5% to $19.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Common Equity were $19.0 million in Q4 2025, $18.5 million in Q3 2025, and $19.4 million in Q2 2025.